PHI-TEN
DEAD

Serial Number

75142235

Owner

Phild Co., Ltd

Attorney

Stacey R. Halpern

Filing Date

Jul 26, 1996

Add to watchlist:

No watchlists yet
View on USPTO

PHI-TEN Trademark

Serial Number: 75142235

PHI-TEN is a trademark filed by Phild Co., Ltd on July 26, 1996. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Phild Co., Ltd (97 trademarks)

4th Fl., Kawamoto Bldg., 110
Kamigyo-ku Kyoto-city, Koyoto Pref , JP

Entity Type: 03

Trademark Details

Filing Date

July 26, 1996

Registration Date

Not Registered

Published for Opposition

April 26, 2005

Goods & Services

drugs for medical purposes, namely, drugs for central nervous system, namely, general anesthetics, hypnotics and sedatives, anti-epileptics, antipyretics and analgesics, nervous system stimulants, analeptics and anti-dizziness agents; drugs for peripheral nervous system, namely, local anesthetics, skeletal muscle relaxants, autonomics, antispasmodics, diaphoretics and anhidrotics; drugs for sensory organs, namely, agents for ophthalmic use and agents for optic and nasal use; drugs used in allergy, namely, anti-histamines and agents for stimulation therapy; drugs affecting circulatory organs, namely, cardiotonics, agents for arrhythmia, diuretics, hypo tensors, vasosupporters, vasoconstrictors and cerebral hemorrhage prophylactic; agents affecting respiratory organs, namely, respiratory stimulants, antitussives and expectorants and cough wheat gluten; agents for digestive organs, namely, organs for dental use, agents for oral use, stomachics and digestives, antacids, anti-emetics, emetics, choleretics, antidiarrheals, purgatives, clysters, stomach and bowels wash powder, tooth prophylactic, stomatic refrigerant, and stomatic cleanser; hormone preparations, namely, pituitary hormone preparations, salivary gland hormone preparations, thyroid and accessory thyroid hormone preparations, pancreas hormone preparations, adrenal hormone preparations, androgens, estrogens and mixed hormone preparations; agents for urinary, genital and anal organs, namely, urinary antiseptics, oxytocics, agents affecting menstruation, contraceptives and anti-hemorrhoidics; agents affecting epidermis, namely, disinfectants, dermatics for purulence, analgesics, anti-itchings, astringents, cataplasms, anti-dermoinfectives, corrosives, hair remedies, bath preparations, medicated baby powder, medicated baby oil, medicated soap of the Japanese pharmacopoeia; vitamin preparations, namely, vitamin A preparations, vitamin B preparations, vitamin C preparations, vitamin D preparations, composite vitamin preparations compounded of water soluble and fat soluble vitamins, mixed vitamin preparations compounded of water soluble and fat soluble vitamins and cod-liver oil drops; amino acids and preparations, namely, lysine, methionin, tryptophane and threonine; preparations, nutrients, tonics and alternatives, namely, calcium, mineral, saccharide, organic acid, proteins, amino acids, organotherapeutics, chondroitin, foodstuff solidifying agent, medicated wine and royal jelly; agents relating to blood, namely, blood substitutes, hemostatics, anticoagulants and blood-plasma; agents affecting metabolism, namely, lipotropic factor preparations, antidotes, agents for treatment of habitual intoxication, lactogoques and enzyme preparations; agents for activating cellular function, namely, chlorophyll preparations and dyes; anti-cancer and anti-sarcoma tumor suppressing agents; agents used in lesion due to physical stimuli, namely, agents used in thermoplegia and agents used in radiation sickness; agents used in lesion due to chemical stimuli, namely, anti-benzolismus, anti-arsenium and anti-chlorine poisoning; antibiotics and preparations, namely, penicillin, streptomycin, chloramphenicol, erythromycin, thiolutin, tetracycline, colistin-polymyxin, mixed antibiotic, salkomycin and trichomycin; chemotherapeutics agents and preparations, namely, sulfonamide, antituberculotic, antisyphilitics and antiliprotic; biological products, namely, vaccines, toxins, toxoids, antitoxins, antibacterial sera, diagnostic acids for biological tests and mixed biological preparations; agents against parasites, namely, antiprozoals and anthelmintics; agents for dispensing use, namely, excipients, ointment bases, solvents, flavoring agents, room deodorizer and medical coloring agents; labeled isotope substance for treatment and diagnosis; narcotics, namely, opium alkaloids, derivatives and preparations, coca alkaloids, derivatives and preparations and synthetic narcotics; veterinary drugs, namely, vaccines, pain relief medication and preparations for treatment of intestinal bacteria; agents for agriculture or public health, namely, disinfectants, insecticides, fumigants, rodenticides, herbicides, germination controllers, hormones for plants, plant rearing agents, soil improving agents, moth repellents, room deodorants and antiseptics; dental restoration compounds, namely, dental cements, dental prosthetic and filling materials; oblates, namely, thin wafers made from wheat meal or capsules for the purpose of wrapping the aforementioned drugs for medical purposes; gauze; capsules for containing aforementioned drugs for medical purposes; ear bandages; menstruation tampons; sanitary napkins; panties incorporating sanitary pads; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid wound dressings; adult diapers; semen for artificial insemination; powdered milk for babies; menstruation bandages

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 20, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 20, 2006 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 19, 2005 NOAM
PUBLISHED FOR OPPOSITION
Apr 26, 2005 PUBO
NOTICE OF PUBLICATION
Apr 6, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 9, 2005 PREV
ASSIGNED TO LIE
Feb 7, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2005 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 16, 2005 XAEC
ASSIGNED TO LIE
Jan 14, 2005 ALIE
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 16, 2004 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 4, 2004 TROA
PETITION TO REVIVE-GRANTED
Nov 4, 2004 PETG
TEAS PETITION TO REVIVE RECEIVED
Nov 4, 2004 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 15, 2004 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 15, 2004 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2004 TCCA
NON-FINAL ACTION MAILED
Mar 19, 2004 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2004 CRFA
PAPER RECEIVED
Feb 11, 2004 MAIL
INQUIRY AS TO SUSPENSION MAILED
Oct 23, 2003 CNSI
CASE FILE IN TICRS
Oct 9, 2003 CFIT
PAPER RECEIVED
Sep 25, 2003 MAIL
LETTER OF SUSPENSION MAILED
Dec 16, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2002 CRFA
PAPER RECEIVED
Nov 26, 2002 MAIL
INQUIRY AS TO SUSPENSION MAILED
Aug 5, 2002 CNSI
INQUIRY AS TO SUSPENSION MAILED
Jul 8, 2002 CNSI
ASSIGNED TO EXAMINER
May 20, 2002 DOCK
LETTER OF SUSPENSION MAILED
Nov 26, 2001 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2001 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2001 CRFA
INQUIRY AS TO SUSPENSION MAILED
Jul 19, 2001 CNSI
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Mar 29, 2001 UNPR
LETTER OF SUSPENSION MAILED
Dec 1, 2000 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2000 CRFA
INQUIRY AS TO SUSPENSION MAILED
Apr 14, 2000 CNSI
LETTER OF SUSPENSION MAILED
Sep 21, 1999 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 1999 CRFA
LETTER OF SUSPENSION MAILED
May 5, 1999 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 1999 CRFA
INQUIRY AS TO SUSPENSION MAILED
Nov 6, 1998 CNSI
LETTER OF SUSPENSION MAILED
May 20, 1998 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 1998 CRFA
FINAL REFUSAL MAILED
Oct 10, 1997 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 1997 CRFA
NON-FINAL ACTION MAILED
Feb 11, 1997 CNRT
ASSIGNED TO EXAMINER
Jan 16, 1997 DOCK
ASSIGNED TO EXAMINER
Jan 10, 1997 DOCK